Schedule 13G ownership disclosure

Biopharmx

Security class unavailable · CUSIP: 09072X101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-18-001616
Form type
SC 13G/A
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Feb 14, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub